Obesity and 30-Day Outcomes Following Minimally Invasive Nephrectomy

Colin D Sperling1, Leilei Xia2, Ian B Berger3

  • 1Cooper Medical School of Rowan University, Camden, NJ; Division of Urology, Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.

Urology
|August 20, 2018
PubMed
Abstract

Insights

Obesity does not independently predict 30-day complications or readmission after minimally invasive nephrectomy. However, it is associated with longer operative times and discharge to continued care, warranting consideration alongside comorbidities.

Area of Science:

  • Urology
  • Surgical Outcomes
  • Nephrology

Background:

  • Minimally invasive partial nephrectomy (MIPN) and radical nephrectomy (MIRN) are standard procedures.
  • The impact of obesity on outcomes after these procedures requires further clarification.

Purpose of the Study:

  • To evaluate the association between obesity and postoperative outcomes following MIPN and MIRN.
  • To determine if body mass index (BMI) independently predicts complications or readmissions.

Main Methods:

  • Analysis of the National Surgical Quality Improvement Project database (2012-2016).
  • Stratification of adult patients by BMI into obesity classes (nonobese, class I, II, III).
  • Multivariable logistic regression models to assess associations between obesity, comorbidity score, and outcomes.

Main Results:

  • Comorbidity score, but not obesity class alone, was associated with increased 30-day postoperative complications when both were in the model.
  • Obesity was not associated with unplanned readmission.
  • Obesity was independently linked to prolonged operative time and discharge to continued care.

Conclusions:

  • BMI alone does not independently predict overall complications or 30-day readmission after MIPN or MIRN.
  • Obesity should be considered with other comorbidities for risk stratification before minimally invasive nephrectomy.
  • Obesity is not a definitive contraindication for these procedures.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
10.9K
Outcomes of Glycolysis01:13

Outcomes of Glycolysis

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.3K
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
4.0K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
268
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
286